Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Profit After Tax

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,941 Cr₹130,968 Cr₹1,453 Cr₹129 Cr₹10,561 Cr

What is the latest Profit After Tax of MANKIND PHARMA ?

The latest Profit After Tax ratio of MANKIND PHARMA is ₹1,941 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,941 Cr
Mar2024₹130,968 Cr
Mar2023₹1,453 Cr
Mar2022₹129 Cr
Mar2021₹10,561 Cr

How is Profit After Tax of MANKIND PHARMA Trending?

Years Profit After Tax % Change
Mar2025 ₹1,941 Cr
-98.52
Mar2024 ₹130,968 Cr
8,913.86
Mar2023 ₹1,453 Cr
1,023.68
Mar2022 ₹129 Cr
-98.78
Mar2021 ₹10,561 Cr -

Compare Profit After Tax of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹92,737.6 Cr -0.9% 10.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.9%

10.1%

-11.6%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses